1. ？MIDWOOD K S, HUSSENET T, LANGLOIS B, et al. Advances in tenascin-C biology[J]. Cell Mol Life Sci, 2011, 68(19):3175-3199.
[2]
2. CHIQUET-EHRISMANN R, TUCKER R P. Tenascins and the importance of adhesion modulation[J]. Cold Spring Harb Perspect Biol, 2011, 3(5): pii: a004960.
[3]
4. NAGAHARU K, ZHANG Xinhui, YOSHIDA T, et al. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells[J]. Am J Pathol, 2011, 178(2): 754-763.
[4]
5. CHONG H C, TAN C K, HUANG R L, et al. Matricellular proteins: a sticky affair with cancers[J]. J Oncol, 2012, 2012: Article ID 351089.
[5]
6. QUIRICO-SANTOS T, FONSECA C O, LAGROTA-CANDIDO J. Brain sweet brain: importance of sugars for the cerebral microenvironment and tumor development[J]. Arq Neuropsiquiatr, 2010, 68(5): 799-803.
[6]
9. SAITO Y, IMAZEKI H, MIURA S, et al. A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4[J]. J Biol Chem, 2007, 282(48): 34929-34937.
[7]
10. PARON I, BERCHTOLD S, V？R？S J, et al. Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway[J]. PLoS One, 2011, 6(6): e21684.
[8]
11. XU Jielin, MAURER L M, HOFFMANN B R, et al. iso-DGR sequences do not mediate binding of fibronectin N-terminal modules to adherent fibronectin-null fibroblasts[J]. J Biol Chem, 2010, 285(12): 8563-8571.
[9]
17. HAU P, KUNZ-SCHUGHART L A, R?MMELE P, et al. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas[J]. J Neurooncol, 2006, 77(1): 1-7.
[10]
18. REINERTSEN T, HALGUNSET J, VISET T, et al. Gene expressional changes in prostate fibroblasts from cancerous tissue[J]. APMIS, 2012, 120(7): 558-571.
[11]
19. KIM M Y, KIM O R, CHOI Y S, et al. Selection and characterization of tenascin C targeting peptide[J]. Mol Cells, 2012, 33(1): 71-77.
[12]
21. O'CONNELL J T, SUGIMOTO H, COOKE V G, et al. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization[J]. Proc Natl Acad Sci U S A, 2011, 108(38): 16002-16007.
[13]
22. BRELLIER F, CHIQUET-EHRISMANN R. How do tenascins influence the birth and life of a malignant cell?[J]. J Cell Mol Med, 2012, 16(1): 32-40.
[14]
23. VAN OBBERGHEN-SCHILLING E, TUCKER R P, SAUPE F, et al. Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth[J]. Int J Dev Biol, 2011, 55(4/5): 511-525.
[15]
24. PEZZOLO A, PARODI F, MARIMPIETRI D, et al. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells[J]. Cell Res, 2011, 21(10): 1470-1486.
[16]
26. RUIZ C, HUANG Wentao, HEGI M E, et al. Growth promoting signaling by tenascin-C [corrected][J]. Cancer Res, 2004, 64(20): 7377-7385.
[17]
27. LANGE K, KAMMERER M, SAUPE F, et al. Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment[J]. Cancer Res, 2008, 68(17): 6942-6952.
[18]
28. OSKARSSON T, ACHARYYA S, ZHANG X H, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs[J]. Nat Med, 2011, 17(7): 867-874.
[19]
29. BEITER K, HIENDLMEYER E, BRABLETZ T, et al. beta-Catenin regulates the expression of tenascin-C in human colorectal tumors[J]. Oncogene, 2005, 24(55): 8200-8204.
[20]
30. SIVASANKARAN B, DEGEN M, GHAFFARI A, et al. Tenascin-C is a novel RBPJκ-induced target gene for Notch signaling in gliomas[J]. Cancer Res, 2009, 69(2): 458-465.
[21]
31. OHYAMA T, NAGATA Takashi, TSUDA K, et al. Structure of Musashi1 in a complex with target RNA: the role of aromatic stacking interactions[J]. Nucleic Acids Res, 2012, 40(7): 3218-3231.
[22]
12. VARGA I, HUTóCZKI G, SZEMCSáK C D, et al. Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma[J]. Pathol Oncol Res, 2012, 18(2): 413-420.
[23]
13. SARKAR S, YONG V W. Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix[J]. Carcinogenesis, 2010, 31(2): 311-317.
[24]
14. GUTTERY D S, HANCOX R A, MULLIGAN K T, et al. Association of invasion-promoting tenascin-C additional domains with breast cancers in young women[J]. Breast Cancer Res, 2010, 12(4): R57.
[25]
3. MIDWOOD K S, OREND G. The role of tenascin-C in tissue injury and tumorigenesis[J]. J Cell Commun Signal, 2009, 3(3-4): 287-310.
[26]
7. ALLEN M D, VAZIRI R, GREEN M, et al. Clinical and functional significance ofα9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion[J]. J Pathol, 2011, 223(5): 646-658.
[27]
8. PAL'TSEVA E M, SAMOFALOVA O, GORBACHEVA IuV, et al. Molecular markers of colorectal adrenocarcinoma progression[J]. Arkh Patol, 2012, 74(2): 14-18.
[28]
15. GRAHOVAC J, BECKER D, WELLS A. Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C[J]. J Invest Dermatol, 2013, 133(1): 210-220.
20. ROLLE K, NOWAK S, WYSZKO E, et al. Promising human brain tumors therapy with interference RNA intervention (iRNAi)[J]. Cancer Biol Ther, 2010, 9(5): 396-406.
[31]
25. HUANG Wentao, CHIQUET-EHRISMANN R, MOYANO J V, et al. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation[J]. Cancer Res, 2001, 61(23): 8586-8594.
